微环境影响胰腺癌的细胞状态,可塑性和药物反应
Srivatsan Raghavan1, Peter S Winter2, Andrew W Navia2
1Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA; Harvard Medical School, Boston, MA 02115, USA; Department of Medicine, Brigham and Women's Hospital, Boston, MA 02115, USA.
Cell
|December 10, 2021
概括
研究人员确定了新的胰腺管腺癌 (PDAC) 细胞状态和瘤微环境 (TMEs). 他们发现在模型中操纵细胞状态可以揭示药物脆弱性, 为癌症研究提供新的框架.
科学领域:
- 癌症学
- 分子生物学
- 基因组学
背景情况:
- 在胰腺管腺癌 (PDAC) 中已知具有预后意义的RNA表达状态,但其驱动因素,稳定性和治疗反应联系尚不清楚.
- 了解这些状态对于开发有效的PDAC治疗至关重要.
研究的目的:
- 系统地调查PDAC中的RNA表达状态的驱动因素,稳定性和治疗反应关系.
- 在体内和体外模型之间调整细胞状态的框架.
主要方法:
- 转移的PDAC活检和匹配的器官模型的单细胞RNA测序.
- 对体内和体外模型进行比较分析,以确定培养特异性偏差.
- 功能性实验以恢复体内相关因素并评估药物反应.
主要成果:
- 确定一种新的PDAC转录细胞状态和独特的瘤微环境 (TMEs).
- 由于TME信号的改变,癌细胞转录状态的培养特异性偏差的证明.
- 在培养模型中恢复表达异质性和细胞状态可塑性的证据.
- 证明非遗传细胞状态调节会影响药物反应,
结论:
- 建立了一个在体内和体外细胞状态调整的框架.
- 在PDAC中确定了转录可塑性的驱动因素.
- 细胞状态操纵可以揭示和准PDAC中的药物漏洞.
相关概念视频
The Tumor Microenvironment
6.9K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.9K
Interactions Between Signaling Pathways
6.6K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.6K
Adaptive Mechanisms in Cancer Cells
6.0K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.0K
Cancer Stem Cells and Tumor Maintenance
5.1K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
5.1K


